{"id":344484,"date":"2025-08-24T08:28:32","date_gmt":"2025-08-24T08:28:32","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-corcept-therapeutics-incorporated\/"},"modified":"2025-08-24T08:28:32","modified_gmt":"2025-08-24T08:28:32","slug":"how-to-buy-corcept-therapeutics-incorporated","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-corcept-therapeutics-incorporated\/","title":{"rendered":"Corcept Therapeutics Incorporated (CORT) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Corcept Therapeutics Incorporated (CORT) Hisse Senedi Yat\u0131r\u0131m\u0131"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334009,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-344484","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"Corcept Therapeutics Incorporated (CORT) Hisseleri Nas\u0131l Al\u0131n\u0131r - Corcept Therapeutics Incorporated (CORT) Hisse Senedi Yat\u0131r\u0131m\u0131","h1_source":{"label":"H1","type":"text","formatted_value":"Corcept Therapeutics Incorporated (CORT) Hisseleri Nas\u0131l Al\u0131n\u0131r - Corcept Therapeutics Incorporated (CORT) Hisse Senedi Yat\u0131r\u0131m\u0131"},"description":"Corcept Therapeutics (CORT) hisselerine nas\u0131l yat\u0131r\u0131m yap\u0131laca\u011f\u0131n\u0131, g\u00fcncel fiyat analizini, 2025 tahminlerini ve maksimum getiri i\u00e7in ad\u0131m ad\u0131m sat\u0131n alma rehberini \u00f6\u011frenin.","description_source":{"label":"Description","type":"textarea","formatted_value":"Corcept Therapeutics (CORT) hisselerine nas\u0131l yat\u0131r\u0131m yap\u0131laca\u011f\u0131n\u0131, g\u00fcncel fiyat analizini, 2025 tahminlerini ve maksimum getiri i\u00e7in ad\u0131m ad\u0131m sat\u0131n alma rehberini \u00f6\u011frenin."},"intro":"Kortizol ara\u015ft\u0131rmalar\u0131nda \u00e7\u0131\u011f\u0131r a\u00e7an bir biyoteknoloji \u015firketine yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Corcept Therapeutics (CORT), t\u0131bbi yenilik ve finansal b\u00fcy\u00fcmenin kesi\u015fim noktas\u0131nda b\u00fcy\u00fcleyici bir f\u0131rsat sunuyor. Nadir metabolik bozukluklar i\u00e7in \u00e7\u0131\u011f\u0131r a\u00e7an tedaviler ve potansiyel dolu bir \u00fcr\u00fcn hatt\u0131 ile bu hisse, \u00f6nemli getiriler i\u00e7in biletiniz olabilir. CORT'un neden dikkatinizi hak etti\u011fini ve bug\u00fcn nas\u0131l hissedar olabilece\u011finizi ke\u015ffedelim.","intro_source":{"label":"Intro","type":"text","formatted_value":"Kortizol ara\u015ft\u0131rmalar\u0131nda \u00e7\u0131\u011f\u0131r a\u00e7an bir biyoteknoloji \u015firketine yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Corcept Therapeutics (CORT), t\u0131bbi yenilik ve finansal b\u00fcy\u00fcmenin kesi\u015fim noktas\u0131nda b\u00fcy\u00fcleyici bir f\u0131rsat sunuyor. Nadir metabolik bozukluklar i\u00e7in \u00e7\u0131\u011f\u0131r a\u00e7an tedaviler ve potansiyel dolu bir \u00fcr\u00fcn hatt\u0131 ile bu hisse, \u00f6nemli getiriler i\u00e7in biletiniz olabilir. CORT'un neden dikkatinizi hak etti\u011fini ve bug\u00fcn nas\u0131l hissedar olabilece\u011finizi ke\u015ffedelim."},"body_html":"<h2>\ud83d\udcc8 CORT Hissesi: G\u00fcncel Fiyat ve Piyasa Konumu<\/h2> <p>24 A\u011fustos 2025 itibar\u0131yla Corcept Therapeutics Incorporated (CORT), NASDAQ borsas\u0131nda <strong>70,40 $<\/strong> seviyesinde i\u015flem g\u00f6r\u00fcyor. Bu fiyat, hissenin 33,34 $ ile 117,33 $ aras\u0131ndaki etkileyici 52 haftal\u0131k aral\u0131\u011f\u0131 g\u00f6z \u00f6n\u00fcne al\u0131nd\u0131\u011f\u0131nda ilgin\u00e7 bir giri\u015f noktas\u0131 sunuyor - biyoteknoloji yat\u0131r\u0131mc\u0131lar\u0131n\u0131n arad\u0131\u011f\u0131 hem volatiliteyi hem de potansiyel y\u00fckseli\u015fi g\u00f6steriyor.<\/p> <p><strong>Takviminize not edin: 29 Ekim 2025 kesinlikle kritik.<\/strong> Corcept, bu tarihte 3. \u00e7eyrek kazan\u00e7 raporunu a\u00e7\u0131klayacak. Tarihsel olarak, bu a\u00e7\u0131klamalar hisseyi dramatik \u015fekilde hareket ettirdi - bazen tek bir seansta \u00e7ift haneli y\u00fczdelerle.<\/p> <h3>Kazan\u00e7 Raporlar\u0131 CORT Hissesini Nas\u0131l Etkiler?<\/h3> <table> <thead> <tr><th>Tarih<\/th><th>Olay<\/th><th>Haber \u00d6ncesi Fiyat<\/th><th>Haber Sonras\u0131 De\u011fi\u015fim<\/th><\/tr> <\/thead> <tbody> <tr><td>31 Tem 2025<\/td><td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>68,50 $<\/td><td>%4,2 Art\u0131\u015f (EPS tahminlerini a\u015ft\u0131)<\/td><\/tr> <tr><td>5 May 2025<\/td><td>1. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>62,80 $<\/td><td>%12,1 Art\u0131\u015f (g\u00fc\u00e7l\u00fc gelir b\u00fcy\u00fcmesi)<\/td><\/tr> <tr><td>31 Mar 2025<\/td><td>FDA Onay\u0131<\/td><td>38,20 $<\/td><td>%83,3 Art\u0131\u015f (Relacorilant onay\u0131)<\/td><\/tr> <tr><td>12 \u015eub 2025<\/td><td>Klinik Sonu\u00e7lar<\/td><td>49,50 $<\/td><td>%8,7 Art\u0131\u015f (pozitif deneme verileri)<\/td><\/tr> <tr><td>8 Kas 2024<\/td><td>\u00dcr\u00fcn Hatt\u0131 G\u00fcncellemesi<\/td><td>42,10 $<\/td><td>%3,2 D\u00fc\u015f\u00fc\u015f (geli\u015ftirme gecikmeleri)<\/td><\/tr> <tr><td>9 A\u011fu 2024<\/td><td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>40,80 $<\/td><td>%5,9 Art\u0131\u015f (rehberlik art\u0131\u015f\u0131)<\/td><\/tr> <\/tbody> <\/table> <p><strong>Trend \u0130\u00e7g\u00f6r\u00fcs\u00fc<\/strong>: Mart ay\u0131ndaki FDA onay\u0131 gibi olumlu d\u00fczenleyici haberler patlay\u0131c\u0131 kazan\u00e7lar yarat\u0131rken, kazan\u00e7lar\u0131n beklentileri a\u015fmas\u0131 genellikle %4-12 aras\u0131nda sa\u011flam getiriler sa\u011flar. Anahtar, bu kataliz\u00f6rler etraf\u0131nda giri\u015f zamanlamas\u0131d\u0131r.<\/p> [cta_green text=\"Ticarete Ba\u015fla\"]<h2>\ud83d\udcca 6 Ayl\u0131k Fiyat Yolculu\u011fu: \u00d6d\u00fcll\u00fc Bir Rollercoaster<\/h2> <p>CORT hisseleri son alt\u0131 ayda \u00e7\u0131lg\u0131n ama karl\u0131 bir seyir izledi:<\/p> <ul> <li><strong>Ocak 2025<\/strong>: 49,00 $ (tatil sonras\u0131 konsolidasyon)<\/li> <li><strong>\u015eubat 2025<\/strong>: 70,01 $ (analist y\u00fckseltmeleriyle istikrarl\u0131 y\u00fckseli\u015f)<\/li> <li><strong>Mart 2025<\/strong>: 117,33 $ (FDA onay\u0131 patlamas\u0131)<\/li> <li><strong>May\u0131s 2025<\/strong>: 85,40 $ (kazan\u00e7 sonras\u0131 kar realizasyonu)<\/li> <li><strong>Temmuz 2025<\/strong>: 72,50 $ (yaz konsolidasyonu)<\/li> <li><strong>A\u011fustos 2025<\/strong>: 70,40 $ (mevcut destek seviyesi)<\/li> <\/ul> <p><strong>Volatilitenin sebebi nedir?<\/strong> Biyoteknoloji hisseleri klinik deneme sonu\u00e7lar\u0131 ve d\u00fczenleyici kararlarla hayat bulur ya da biter. CORT'un %238'lik i\u015flem aral\u0131\u011f\u0131 bu sekt\u00f6r\u00fcn hem risklerini hem de \u00f6d\u00fcllerini yans\u0131t\u0131yor.<\/p> <p>Hissenin Mart zirvelerinden sonraki geri \u00e7ekilmesi asl\u0131nda cazip bir risk-getiri dengesi yarat\u0131yor. Zirvenin %40 alt\u0131nda seviyelerden al\u0131m yap\u0131yorsunuz ancak yine de y\u0131ll\u0131k bazda sa\u011flam kazan\u00e7lar sunuyor.<\/p> <h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2> <ul> <li><strong>2025 Y\u0131l Sonu<\/strong>: 125-140 $ (4. \u00e7eyrek kazan\u00e7 a\u015f\u0131m\u0131 ve \u00fcr\u00fcn hatt\u0131 ilerlemesine dayanarak) \u2192 <strong>G\u00dc\u00c7L\u00dc AL<\/strong><\/li> <li><strong>2026 Projeksiyonu<\/strong>: 150-175 $ (tam y\u0131l Relacorilant geliri + yeni endikasyonlar)<\/li> <li><strong>2028 G\u00f6r\u00fcn\u00fcm\u00fc<\/strong>: 200-250 $ (\u00e7e\u015fitlendirilmi\u015f \u00fcr\u00fcn portf\u00f6y\u00fc + uluslararas\u0131 geni\u015fleme)<\/li> <li><strong>2030 Vizyonu<\/strong>: 300+ $ (kortizol mod\u00fclasyon terapilerinde pazar liderli\u011fi)<\/li> <\/ul> <p><strong>Sonu\u00e7<\/strong>: Bu, sabr\u0131n b\u00fcy\u00fck temett\u00fcler getirdi\u011fi klasik bir b\u00fcy\u00fcme hikayesi. Mevcut d\u00fc\u015f\u00fc\u015f, uzun vadeli yat\u0131r\u0131mc\u0131lar i\u00e7in alt\u0131n bir f\u0131rsat sunuyor.<\/p> <h2>\u26a0\ufe0f Temel Riskler ve Olumlu Sinyaller<\/h2> <h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3> <ul> <li><strong>D\u00fczenleyici ba\u011f\u0131ml\u0131l\u0131k<\/strong>: FDA kararlar\u0131 hisseyi bir gecede y\u00fckseltebilir ya da d\u00fc\u015f\u00fcrebilir<\/li> <li><strong>Klinik deneme ba\u015far\u0131s\u0131zl\u0131klar\u0131<\/strong>: Herhangi bir olumsuz veri de\u011ferin %30-50'sini h\u0131zla silebilir<\/li> <li><strong>Korlym konsantrasyonu<\/strong>: Tek bir \u00fcr\u00fcne a\u015f\u0131r\u0131 ba\u011f\u0131ml\u0131l\u0131k k\u0131r\u0131lganl\u0131k yarat\u0131r<\/li> <li><strong>De\u011ferleme endi\u015feleri<\/strong>: 62 F\/K oran\u0131 hayal k\u0131r\u0131kl\u0131\u011f\u0131na az alan b\u0131rak\u0131yor<\/li> <\/ul> <h3>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3> <ul> <li><strong>FDA ivmesi<\/strong>: Son Relacorilant onay\u0131 d\u00fczenleyici deste\u011fi g\u00f6steriyor<\/li> <li><strong>Gelir b\u00fcy\u00fcmesi<\/strong>: 2026'ya kadar y\u0131ll\u0131k %35 b\u00fcy\u00fcme \u00f6ng\u00f6r\u00fcl\u00fcyor<\/li> <li><strong>Analist deste\u011fi<\/strong>: <a href=\"https:\/\/www.marketbeat.com\/instant-alerts\/corcept-therapeutics-nasdaqcort-price-target-cut-to-13700-by-analysts-at-canaccord-genuity-group-2025-08-01\/\">Canaccord Genuity'nin 137 $ hedefi<\/a> %95 yukar\u0131 potansiyel sunuyor<\/li> <li><strong>\u00dcr\u00fcn hatt\u0131 derinli\u011fi<\/strong>: Geli\u015ftirme a\u015famas\u0131nda birden fazla ila\u00e7 tek \u00fcr\u00fcn riskini azalt\u0131yor<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2> <ol> <li><strong>K\u00fc\u00e7\u00fck ba\u015flay\u0131n<\/strong> - Portf\u00f6y\u00fcn\u00fcz\u00fcn %5'inden fazlas\u0131n\u0131 y\u00fcksek volatiliteye sahip biyoteknolojiye ay\u0131rmay\u0131n<\/li> <li><strong>Dolar maliyeti ortalamas\u0131 kullan\u0131n<\/strong> - Tek seferde de\u011fil, haftal\u0131k taksitlerle al\u0131m yap\u0131n<\/li> <li><strong>Fiyat uyar\u0131lar\u0131 kurun<\/strong> - Daha fazla zay\u0131fl\u0131k g\u00f6r\u00fcrsek 65-68 $ civar\u0131nda giri\u015f yap\u0131n<\/li> <li><strong>Kazan\u00e7lar boyunca tutun<\/strong> - 29 Ekim b\u00fcy\u00fck bir kataliz\u00f6r olabilir<\/li> <\/ol> <p><strong>Esprili yorum<\/strong>: \"CORT ile i\u015flem yapmak, dahi bir bilim insan\u0131yla \u00e7\u0131kmak gibidir - inan\u0131lmaz \u00f6d\u00fcllendirici ama dramatik ruh hali de\u011fi\u015fimlerine a\u00e7\u0131k. Sab\u0131rl\u0131 olun ve ke\u015fif s\u00fcrecinin tad\u0131n\u0131 \u00e7\u0131kar\u0131n!\"<\/p> <h2>\u2705 Corcept Therapeutics Incorporated (CORT) Hisseleri Nas\u0131l Al\u0131n\u0131r - Ad\u0131m Ad\u0131m<\/h2> <table> <thead> <tr><th>Ad\u0131m<\/th><th>\u0130\u015flem<\/th><th>Neden \u00d6nemli<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Bir i\u015flem platformu se\u00e7in<\/td><td>NASDAQ listeleri ve kesirli hisse sunmas\u0131na dikkat edin<\/td><\/tr> <tr><td>2<\/td><td>Hesap fonlamas\u0131n\u0131 tamamlay\u0131n<\/td><td>Kaybetmeyi g\u00f6ze alabilece\u011finiz bir miktarla ba\u015flay\u0131n<\/td><\/tr> <tr><td>3<\/td><td>\"CORT\" aramas\u0131 yap\u0131n<\/td><td>\u015eirket ad\u0131 de\u011fil, sembol\u00fc kullan\u0131n<\/td><\/tr> <tr><td>4<\/td><td>Sipari\u015f t\u00fcr\u00fcn\u00fc se\u00e7in<\/td><td>Giri\u015f fiyat\u0131n\u0131z\u0131 kontrol etmek i\u00e7in limit emirleri kullan\u0131n<\/td><\/tr> <tr><td>5<\/td><td>\u0130nceleyin ve onaylay\u0131n<\/td><td>\u00dccretleri ve sipari\u015f detaylar\u0131n\u0131 iki kez kontrol edin<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 Pocket Option Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Neden Uygun?<\/h2> <p>Yat\u0131r\u0131m yolculu\u011funa yeni ba\u015flayanlar i\u00e7in Pocket Option, CORT yat\u0131r\u0131mlar\u0131n\u0131 eri\u015filebilir k\u0131lan birka\u00e7 avantaj sunar:<\/p> <ul> <li><strong>Sadece 5 $ minimum depozito<\/strong> - Ger\u00e7ek para ile stratejileri test etmek i\u00e7in m\u00fckemmel, ancak d\u00fc\u015f\u00fck riskli<\/li> <li><strong>\u015eim\u015fek h\u0131z\u0131nda do\u011frulama<\/strong> - Herhangi bir kimlik belgesini y\u00fckleyin ve dakikalar i\u00e7inde i\u015flem yapmaya ba\u015flay\u0131n<\/li> <li><strong>\u00c7e\u015fitli para \u00e7ekme se\u00e7enekleri<\/strong> - Kripto ve e-c\u00fczdanlar dahil 100'den fazla y\u00f6ntemle karlar\u0131n\u0131za eri\u015fin<\/li> <\/ul> <p>Platformun kullan\u0131c\u0131 dostu aray\u00fcz\u00fc, biyoteknoloji volatilitesinde gezinmeyi yeni ba\u015flayanlar i\u00e7in \u00e7ok daha az korkutucu hale getiriyor.<\/p> <h2>\ud83c\udf0d 2025'te Corcept Therapeutics: Kortizol Yenilik Lideri<\/h2> <p>Corcept Therapeutics, kortizol mod\u00fclasyon terapileri alan\u0131nda y\u00fckselen bir liderdir. \u015eirketin amiral gemisi ilac\u0131 Korlym\u00ae, Cushing sendromunu tedavi ederken, yeni onaylanan Relacorilant pazar eri\u015fimini \u00f6nemli \u00f6l\u00e7\u00fcde geni\u015fletiyor.<\/p> <p>\u015eirket, <a href=\"https:\/\/simplywall.st\/stocks\/us\/pharmaceuticals-biotech\/nasdaq-cort\/corcept-therapeutics\/news\/how-corcepts-earnings-beat-and-buyback-expansion-could-shape\">2025 gelirini 850-900 milyon $<\/a> olarak projekte ediyor; bu, sadece birka\u00e7 y\u0131l \u00f6ncesine g\u00f6re muazzam bir b\u00fcy\u00fcme anlam\u0131na geliyor. Geli\u015ftirme a\u015famas\u0131nda 300'den fazla patentli molek\u00fcl ile Corcept, ba\u015far\u0131ya doymuyor.<\/p> <p><strong>\u0130lgin\u00e7 Bilgi<\/strong>: 2025 y\u0131l\u0131nda Corcept ara\u015ft\u0131rmac\u0131lar\u0131, kortizol mod\u00fclat\u00f6rlerinin pandemi kaynakl\u0131 stres bozukluklar\u0131na yard\u0131mc\u0131 olabilece\u011fini ke\u015ffettiler - COVID d\u00f6nemine ait bir sorunu potansiyel olarak milyarlarca dolarl\u0131k bir pazar f\u0131rsat\u0131na d\u00f6n\u00fc\u015ft\u00fcrerek!<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 CORT Hissesi: G\u00fcncel Fiyat ve Piyasa Konumu<\/h2>\n<p>24 A\u011fustos 2025 itibar\u0131yla Corcept Therapeutics Incorporated (CORT), NASDAQ borsas\u0131nda <strong>70,40 $<\/strong> seviyesinde i\u015flem g\u00f6r\u00fcyor. Bu fiyat, hissenin 33,34 $ ile 117,33 $ aras\u0131ndaki etkileyici 52 haftal\u0131k aral\u0131\u011f\u0131 g\u00f6z \u00f6n\u00fcne al\u0131nd\u0131\u011f\u0131nda ilgin\u00e7 bir giri\u015f noktas\u0131 sunuyor &#8211; biyoteknoloji yat\u0131r\u0131mc\u0131lar\u0131n\u0131n arad\u0131\u011f\u0131 hem volatiliteyi hem de potansiyel y\u00fckseli\u015fi g\u00f6steriyor.<\/p>\n<p><strong>Takviminize not edin: 29 Ekim 2025 kesinlikle kritik.<\/strong> Corcept, bu tarihte 3. \u00e7eyrek kazan\u00e7 raporunu a\u00e7\u0131klayacak. Tarihsel olarak, bu a\u00e7\u0131klamalar hisseyi dramatik \u015fekilde hareket ettirdi &#8211; bazen tek bir seansta \u00e7ift haneli y\u00fczdelerle.<\/p>\n<h3>Kazan\u00e7 Raporlar\u0131 CORT Hissesini Nas\u0131l Etkiler?<\/h3>\n<table>\n<thead>\n<tr>\n<th>Tarih<\/th>\n<th>Olay<\/th>\n<th>Haber \u00d6ncesi Fiyat<\/th>\n<th>Haber Sonras\u0131 De\u011fi\u015fim<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>31 Tem 2025<\/td>\n<td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>68,50 $<\/td>\n<td>%4,2 Art\u0131\u015f (EPS tahminlerini a\u015ft\u0131)<\/td>\n<\/tr>\n<tr>\n<td>5 May 2025<\/td>\n<td>1. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>62,80 $<\/td>\n<td>%12,1 Art\u0131\u015f (g\u00fc\u00e7l\u00fc gelir b\u00fcy\u00fcmesi)<\/td>\n<\/tr>\n<tr>\n<td>31 Mar 2025<\/td>\n<td>FDA Onay\u0131<\/td>\n<td>38,20 $<\/td>\n<td>%83,3 Art\u0131\u015f (Relacorilant onay\u0131)<\/td>\n<\/tr>\n<tr>\n<td>12 \u015eub 2025<\/td>\n<td>Klinik Sonu\u00e7lar<\/td>\n<td>49,50 $<\/td>\n<td>%8,7 Art\u0131\u015f (pozitif deneme verileri)<\/td>\n<\/tr>\n<tr>\n<td>8 Kas 2024<\/td>\n<td>\u00dcr\u00fcn Hatt\u0131 G\u00fcncellemesi<\/td>\n<td>42,10 $<\/td>\n<td>%3,2 D\u00fc\u015f\u00fc\u015f (geli\u015ftirme gecikmeleri)<\/td>\n<\/tr>\n<tr>\n<td>9 A\u011fu 2024<\/td>\n<td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>40,80 $<\/td>\n<td>%5,9 Art\u0131\u015f (rehberlik art\u0131\u015f\u0131)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>Trend \u0130\u00e7g\u00f6r\u00fcs\u00fc<\/strong>: Mart ay\u0131ndaki FDA onay\u0131 gibi olumlu d\u00fczenleyici haberler patlay\u0131c\u0131 kazan\u00e7lar yarat\u0131rken, kazan\u00e7lar\u0131n beklentileri a\u015fmas\u0131 genellikle %4-12 aras\u0131nda sa\u011flam getiriler sa\u011flar. Anahtar, bu kataliz\u00f6rler etraf\u0131nda giri\u015f zamanlamas\u0131d\u0131r.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/tr\/register\/\" class=\"po-cta-green\">Ticarete Ba\u015fla\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udcca 6 Ayl\u0131k Fiyat Yolculu\u011fu: \u00d6d\u00fcll\u00fc Bir Rollercoaster<\/h2>\n<p>CORT hisseleri son alt\u0131 ayda \u00e7\u0131lg\u0131n ama karl\u0131 bir seyir izledi:<\/p>\n<ul>\n<li><strong>Ocak 2025<\/strong>: 49,00 $ (tatil sonras\u0131 konsolidasyon)<\/li>\n<li><strong>\u015eubat 2025<\/strong>: 70,01 $ (analist y\u00fckseltmeleriyle istikrarl\u0131 y\u00fckseli\u015f)<\/li>\n<li><strong>Mart 2025<\/strong>: 117,33 $ (FDA onay\u0131 patlamas\u0131)<\/li>\n<li><strong>May\u0131s 2025<\/strong>: 85,40 $ (kazan\u00e7 sonras\u0131 kar realizasyonu)<\/li>\n<li><strong>Temmuz 2025<\/strong>: 72,50 $ (yaz konsolidasyonu)<\/li>\n<li><strong>A\u011fustos 2025<\/strong>: 70,40 $ (mevcut destek seviyesi)<\/li>\n<\/ul>\n<p><strong>Volatilitenin sebebi nedir?<\/strong> Biyoteknoloji hisseleri klinik deneme sonu\u00e7lar\u0131 ve d\u00fczenleyici kararlarla hayat bulur ya da biter. CORT&#8217;un %238&#8217;lik i\u015flem aral\u0131\u011f\u0131 bu sekt\u00f6r\u00fcn hem risklerini hem de \u00f6d\u00fcllerini yans\u0131t\u0131yor.<\/p>\n<p>Hissenin Mart zirvelerinden sonraki geri \u00e7ekilmesi asl\u0131nda cazip bir risk-getiri dengesi yarat\u0131yor. Zirvenin %40 alt\u0131nda seviyelerden al\u0131m yap\u0131yorsunuz ancak yine de y\u0131ll\u0131k bazda sa\u011flam kazan\u00e7lar sunuyor.<\/p>\n<h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2>\n<ul>\n<li><strong>2025 Y\u0131l Sonu<\/strong>: 125-140 $ (4. \u00e7eyrek kazan\u00e7 a\u015f\u0131m\u0131 ve \u00fcr\u00fcn hatt\u0131 ilerlemesine dayanarak) \u2192 <strong>G\u00dc\u00c7L\u00dc AL<\/strong><\/li>\n<li><strong>2026 Projeksiyonu<\/strong>: 150-175 $ (tam y\u0131l Relacorilant geliri + yeni endikasyonlar)<\/li>\n<li><strong>2028 G\u00f6r\u00fcn\u00fcm\u00fc<\/strong>: 200-250 $ (\u00e7e\u015fitlendirilmi\u015f \u00fcr\u00fcn portf\u00f6y\u00fc + uluslararas\u0131 geni\u015fleme)<\/li>\n<li><strong>2030 Vizyonu<\/strong>: 300+ $ (kortizol mod\u00fclasyon terapilerinde pazar liderli\u011fi)<\/li>\n<\/ul>\n<p><strong>Sonu\u00e7<\/strong>: Bu, sabr\u0131n b\u00fcy\u00fck temett\u00fcler getirdi\u011fi klasik bir b\u00fcy\u00fcme hikayesi. Mevcut d\u00fc\u015f\u00fc\u015f, uzun vadeli yat\u0131r\u0131mc\u0131lar i\u00e7in alt\u0131n bir f\u0131rsat sunuyor.<\/p>\n<h2>\u26a0\ufe0f Temel Riskler ve Olumlu Sinyaller<\/h2>\n<h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3>\n<ul>\n<li><strong>D\u00fczenleyici ba\u011f\u0131ml\u0131l\u0131k<\/strong>: FDA kararlar\u0131 hisseyi bir gecede y\u00fckseltebilir ya da d\u00fc\u015f\u00fcrebilir<\/li>\n<li><strong>Klinik deneme ba\u015far\u0131s\u0131zl\u0131klar\u0131<\/strong>: Herhangi bir olumsuz veri de\u011ferin %30-50&#8217;sini h\u0131zla silebilir<\/li>\n<li><strong>Korlym konsantrasyonu<\/strong>: Tek bir \u00fcr\u00fcne a\u015f\u0131r\u0131 ba\u011f\u0131ml\u0131l\u0131k k\u0131r\u0131lganl\u0131k yarat\u0131r<\/li>\n<li><strong>De\u011ferleme endi\u015feleri<\/strong>: 62 F\/K oran\u0131 hayal k\u0131r\u0131kl\u0131\u011f\u0131na az alan b\u0131rak\u0131yor<\/li>\n<\/ul>\n<h3>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3>\n<ul>\n<li><strong>FDA ivmesi<\/strong>: Son Relacorilant onay\u0131 d\u00fczenleyici deste\u011fi g\u00f6steriyor<\/li>\n<li><strong>Gelir b\u00fcy\u00fcmesi<\/strong>: 2026&#8217;ya kadar y\u0131ll\u0131k %35 b\u00fcy\u00fcme \u00f6ng\u00f6r\u00fcl\u00fcyor<\/li>\n<li><strong>Analist deste\u011fi<\/strong>: <a href=\"https:\/\/www.marketbeat.com\/instant-alerts\/corcept-therapeutics-nasdaqcort-price-target-cut-to-13700-by-analysts-at-canaccord-genuity-group-2025-08-01\/\">Canaccord Genuity&#8217;nin 137 $ hedefi<\/a> %95 yukar\u0131 potansiyel sunuyor<\/li>\n<li><strong>\u00dcr\u00fcn hatt\u0131 derinli\u011fi<\/strong>: Geli\u015ftirme a\u015famas\u0131nda birden fazla ila\u00e7 tek \u00fcr\u00fcn riskini azalt\u0131yor<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2>\n<ol>\n<li><strong>K\u00fc\u00e7\u00fck ba\u015flay\u0131n<\/strong> &#8211; Portf\u00f6y\u00fcn\u00fcz\u00fcn %5&#8217;inden fazlas\u0131n\u0131 y\u00fcksek volatiliteye sahip biyoteknolojiye ay\u0131rmay\u0131n<\/li>\n<li><strong>Dolar maliyeti ortalamas\u0131 kullan\u0131n<\/strong> &#8211; Tek seferde de\u011fil, haftal\u0131k taksitlerle al\u0131m yap\u0131n<\/li>\n<li><strong>Fiyat uyar\u0131lar\u0131 kurun<\/strong> &#8211; Daha fazla zay\u0131fl\u0131k g\u00f6r\u00fcrsek 65-68 $ civar\u0131nda giri\u015f yap\u0131n<\/li>\n<li><strong>Kazan\u00e7lar boyunca tutun<\/strong> &#8211; 29 Ekim b\u00fcy\u00fck bir kataliz\u00f6r olabilir<\/li>\n<\/ol>\n<p><strong>Esprili yorum<\/strong>: &#8220;CORT ile i\u015flem yapmak, dahi bir bilim insan\u0131yla \u00e7\u0131kmak gibidir &#8211; inan\u0131lmaz \u00f6d\u00fcllendirici ama dramatik ruh hali de\u011fi\u015fimlerine a\u00e7\u0131k. Sab\u0131rl\u0131 olun ve ke\u015fif s\u00fcrecinin tad\u0131n\u0131 \u00e7\u0131kar\u0131n!&#8221;<\/p>\n<h2>\u2705 Corcept Therapeutics Incorporated (CORT) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Ad\u0131m Ad\u0131m<\/h2>\n<table>\n<thead>\n<tr>\n<th>Ad\u0131m<\/th>\n<th>\u0130\u015flem<\/th>\n<th>Neden \u00d6nemli<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Bir i\u015flem platformu se\u00e7in<\/td>\n<td>NASDAQ listeleri ve kesirli hisse sunmas\u0131na dikkat edin<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Hesap fonlamas\u0131n\u0131 tamamlay\u0131n<\/td>\n<td>Kaybetmeyi g\u00f6ze alabilece\u011finiz bir miktarla ba\u015flay\u0131n<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>&#8220;CORT&#8221; aramas\u0131 yap\u0131n<\/td>\n<td>\u015eirket ad\u0131 de\u011fil, sembol\u00fc kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Sipari\u015f t\u00fcr\u00fcn\u00fc se\u00e7in<\/td>\n<td>Giri\u015f fiyat\u0131n\u0131z\u0131 kontrol etmek i\u00e7in limit emirleri kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>\u0130nceleyin ve onaylay\u0131n<\/td>\n<td>\u00dccretleri ve sipari\u015f detaylar\u0131n\u0131 iki kez kontrol edin<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Pocket Option Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Neden Uygun?<\/h2>\n<p>Yat\u0131r\u0131m yolculu\u011funa yeni ba\u015flayanlar i\u00e7in Pocket Option, CORT yat\u0131r\u0131mlar\u0131n\u0131 eri\u015filebilir k\u0131lan birka\u00e7 avantaj sunar:<\/p>\n<ul>\n<li><strong>Sadece 5 $ minimum depozito<\/strong> &#8211; Ger\u00e7ek para ile stratejileri test etmek i\u00e7in m\u00fckemmel, ancak d\u00fc\u015f\u00fck riskli<\/li>\n<li><strong>\u015eim\u015fek h\u0131z\u0131nda do\u011frulama<\/strong> &#8211; Herhangi bir kimlik belgesini y\u00fckleyin ve dakikalar i\u00e7inde i\u015flem yapmaya ba\u015flay\u0131n<\/li>\n<li><strong>\u00c7e\u015fitli para \u00e7ekme se\u00e7enekleri<\/strong> &#8211; Kripto ve e-c\u00fczdanlar dahil 100&#8217;den fazla y\u00f6ntemle karlar\u0131n\u0131za eri\u015fin<\/li>\n<\/ul>\n<p>Platformun kullan\u0131c\u0131 dostu aray\u00fcz\u00fc, biyoteknoloji volatilitesinde gezinmeyi yeni ba\u015flayanlar i\u00e7in \u00e7ok daha az korkutucu hale getiriyor.<\/p>\n<h2>\ud83c\udf0d 2025&#8217;te Corcept Therapeutics: Kortizol Yenilik Lideri<\/h2>\n<p>Corcept Therapeutics, kortizol mod\u00fclasyon terapileri alan\u0131nda y\u00fckselen bir liderdir. \u015eirketin amiral gemisi ilac\u0131 Korlym\u00ae, Cushing sendromunu tedavi ederken, yeni onaylanan Relacorilant pazar eri\u015fimini \u00f6nemli \u00f6l\u00e7\u00fcde geni\u015fletiyor.<\/p>\n<p>\u015eirket, <a href=\"https:\/\/simplywall.st\/stocks\/us\/pharmaceuticals-biotech\/nasdaq-cort\/corcept-therapeutics\/news\/how-corcepts-earnings-beat-and-buyback-expansion-could-shape\">2025 gelirini 850-900 milyon $<\/a> olarak projekte ediyor; bu, sadece birka\u00e7 y\u0131l \u00f6ncesine g\u00f6re muazzam bir b\u00fcy\u00fcme anlam\u0131na geliyor. Geli\u015ftirme a\u015famas\u0131nda 300&#8217;den fazla patentli molek\u00fcl ile Corcept, ba\u015far\u0131ya doymuyor.<\/p>\n<p><strong>\u0130lgin\u00e7 Bilgi<\/strong>: 2025 y\u0131l\u0131nda Corcept ara\u015ft\u0131rmac\u0131lar\u0131, kortizol mod\u00fclat\u00f6rlerinin pandemi kaynakl\u0131 stres bozukluklar\u0131na yard\u0131mc\u0131 olabilece\u011fini ke\u015ffettiler &#8211; COVID d\u00f6nemine ait bir sorunu potansiyel olarak milyarlarca dolarl\u0131k bir pazar f\u0131rsat\u0131na d\u00f6n\u00fc\u015ft\u00fcrerek!<\/p>\n"},"faq":[{"question":"Corcept Therapeutics hisseleri nas\u0131l sat\u0131n al\u0131n\u0131r?","answer":"Bir i\u015flem platformu se\u00e7in, hesab\u0131n\u0131z\u0131 fonlay\u0131n, \"CORT\" sembol\u00fc ile arama yap\u0131n, limit emri verin ve i\u015flemi onaylay\u0131n."},{"question":"CORT hissesinin 2025 sonu fiyat tahmini nedir?","answer":"2025 y\u0131l sonu i\u00e7in fiyat tahmini 125-140 $ aral\u0131\u011f\u0131nda olup, g\u00fc\u00e7l\u00fc bir al\u0131m sinyali olarak de\u011ferlendirilmektedir."},{"question":"Corcept Therapeutics'in ana \u00fcr\u00fcn\u00fc nedir?","answer":"\u015eirketin ana \u00fcr\u00fcn\u00fc Korlym\u00ae olup, Cushing sendromunun tedavisinde kullan\u0131lmaktad\u0131r."},{"question":"CORT hissesinde hangi riskler bulunmaktad\u0131r?","answer":"FDA kararlar\u0131na ba\u011f\u0131ml\u0131l\u0131k, klinik deneme ba\u015far\u0131s\u0131zl\u0131klar\u0131, tek \u00fcr\u00fcne a\u015f\u0131r\u0131 ba\u011f\u0131ml\u0131l\u0131k ve y\u00fcksek de\u011ferleme riskleri bulunmaktad\u0131r."},{"question":"Yeni ba\u015flayanlar CORT hissesi al\u0131rken nelere dikkat etmeli?","answer":"Portf\u00f6y\u00fcn %5'inden fazlas\u0131n\u0131 ay\u0131rmamak, dolar maliyeti ortalamas\u0131 yapmak, fiyat uyar\u0131lar\u0131 kurmak ve \u00f6nemli kazan\u00e7 raporlar\u0131 s\u0131ras\u0131nda pozisyonu korumak \u00f6nemlidir."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Corcept Therapeutics hisseleri nas\u0131l sat\u0131n al\u0131n\u0131r?","answer":"Bir i\u015flem platformu se\u00e7in, hesab\u0131n\u0131z\u0131 fonlay\u0131n, \"CORT\" sembol\u00fc ile arama yap\u0131n, limit emri verin ve i\u015flemi onaylay\u0131n."},{"question":"CORT hissesinin 2025 sonu fiyat tahmini nedir?","answer":"2025 y\u0131l sonu i\u00e7in fiyat tahmini 125-140 $ aral\u0131\u011f\u0131nda olup, g\u00fc\u00e7l\u00fc bir al\u0131m sinyali olarak de\u011ferlendirilmektedir."},{"question":"Corcept Therapeutics'in ana \u00fcr\u00fcn\u00fc nedir?","answer":"\u015eirketin ana \u00fcr\u00fcn\u00fc Korlym\u00ae olup, Cushing sendromunun tedavisinde kullan\u0131lmaktad\u0131r."},{"question":"CORT hissesinde hangi riskler bulunmaktad\u0131r?","answer":"FDA kararlar\u0131na ba\u011f\u0131ml\u0131l\u0131k, klinik deneme ba\u015far\u0131s\u0131zl\u0131klar\u0131, tek \u00fcr\u00fcne a\u015f\u0131r\u0131 ba\u011f\u0131ml\u0131l\u0131k ve y\u00fcksek de\u011ferleme riskleri bulunmaktad\u0131r."},{"question":"Yeni ba\u015flayanlar CORT hissesi al\u0131rken nelere dikkat etmeli?","answer":"Portf\u00f6y\u00fcn %5'inden fazlas\u0131n\u0131 ay\u0131rmamak, dolar maliyeti ortalamas\u0131 yapmak, fiyat uyar\u0131lar\u0131 kurmak ve \u00f6nemli kazan\u00e7 raporlar\u0131 s\u0131ras\u0131nda pozisyonu korumak \u00f6nemlidir."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Corcept Therapeutics Incorporated (CORT) Hisseleri Nas\u0131l Al\u0131n\u0131r - Corcept Therapeutics Incorporated (CORT) Hisse Senedi Yat\u0131r\u0131m\u0131<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-corcept-therapeutics-incorporated\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Corcept Therapeutics Incorporated (CORT) Hisseleri Nas\u0131l Al\u0131n\u0131r - Corcept Therapeutics Incorporated (CORT) Hisse Senedi Yat\u0131r\u0131m\u0131\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-corcept-therapeutics-incorporated\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-24T08:28:32+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-corcept-therapeutics-incorporated\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-corcept-therapeutics-incorporated\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"Corcept Therapeutics Incorporated (CORT) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Corcept Therapeutics Incorporated (CORT) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"datePublished\":\"2025-08-24T08:28:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-corcept-therapeutics-incorporated\/\"},\"wordCount\":21,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-corcept-therapeutics-incorporated\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-corcept-therapeutics-incorporated\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-corcept-therapeutics-incorporated\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-corcept-therapeutics-incorporated\/\",\"name\":\"Corcept Therapeutics Incorporated (CORT) Hisseleri Nas\u0131l Al\u0131n\u0131r - Corcept Therapeutics Incorporated (CORT) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-corcept-therapeutics-incorporated\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-corcept-therapeutics-incorporated\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp\",\"datePublished\":\"2025-08-24T08:28:32+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-corcept-therapeutics-incorporated\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-corcept-therapeutics-incorporated\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-corcept-therapeutics-incorporated\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp\",\"width\":1024,\"height\":576},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-corcept-therapeutics-incorporated\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Corcept Therapeutics Incorporated (CORT) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Corcept Therapeutics Incorporated (CORT) Hisse Senedi Yat\u0131r\u0131m\u0131\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Corcept Therapeutics Incorporated (CORT) Hisseleri Nas\u0131l Al\u0131n\u0131r - Corcept Therapeutics Incorporated (CORT) Hisse Senedi Yat\u0131r\u0131m\u0131","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-corcept-therapeutics-incorporated\/","og_locale":"tr_TR","og_type":"article","og_title":"Corcept Therapeutics Incorporated (CORT) Hisseleri Nas\u0131l Al\u0131n\u0131r - Corcept Therapeutics Incorporated (CORT) Hisse Senedi Yat\u0131r\u0131m\u0131","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-corcept-therapeutics-incorporated\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-24T08:28:32+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-corcept-therapeutics-incorporated\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-corcept-therapeutics-incorporated\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"Corcept Therapeutics Incorporated (CORT) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Corcept Therapeutics Incorporated (CORT) Hisse Senedi Yat\u0131r\u0131m\u0131","datePublished":"2025-08-24T08:28:32+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-corcept-therapeutics-incorporated\/"},"wordCount":21,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-corcept-therapeutics-incorporated\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-corcept-therapeutics-incorporated\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-corcept-therapeutics-incorporated\/","url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-corcept-therapeutics-incorporated\/","name":"Corcept Therapeutics Incorporated (CORT) Hisseleri Nas\u0131l Al\u0131n\u0131r - Corcept Therapeutics Incorporated (CORT) Hisse Senedi Yat\u0131r\u0131m\u0131","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-corcept-therapeutics-incorporated\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-corcept-therapeutics-incorporated\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp","datePublished":"2025-08-24T08:28:32+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-corcept-therapeutics-incorporated\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-corcept-therapeutics-incorporated\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-corcept-therapeutics-incorporated\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp","width":1024,"height":576},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-corcept-therapeutics-incorporated\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/tr\/"},{"@type":"ListItem","position":2,"name":"Corcept Therapeutics Incorporated (CORT) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Corcept Therapeutics Incorporated (CORT) Hisse Senedi Yat\u0131r\u0131m\u0131"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/tr\/#website","url":"https:\/\/pocketoption.com\/blog\/tr\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"tr_TR","wpml_translations":{"vt_VT":{"locale":"vt_VT","id":344478,"slug":"how-to-buy-corcept-therapeutics-incorporated","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Corcept Therapeutics Incorporated (CORT) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Corcept Therapeutics Incorporated (CORT)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-corcept-therapeutics-incorporated\/"},"pt_AA":{"locale":"pt_AA","id":344483,"slug":"how-to-buy-corcept-therapeutics-incorporated","post_title":"Como comprar a\u00e7\u00f5es da Corcept Therapeutics Incorporated (CORT) - Investimento em a\u00e7\u00f5es da Corcept Therapeutics Incorporated (CORT)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-corcept-therapeutics-incorporated\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/344484","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/comments?post=344484"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/344484\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media\/334009"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media?parent=344484"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/categories?post=344484"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/tags?post=344484"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}